Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hinton

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
International Journal of Electronic Healthcare|December 1, 2007
Barriers to e-health business processesSuzanne Mieczkowska, Matthew Hinton, David Barnes
Hospital Pharmacy|October 20, 2025
Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzoDavid Zingale, Raymond Lamore, Derek Peiffer, et al.
Open Forum Infectious Diseases|August 13, 2025
Clinical Microbiology in Xylazine-Associated Wound InfectionsDeanna M Berg, Amanda Binkley, Sean D Foster, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
International Journal of Electronic Healthcare|December 1, 2007
Barriers to e-health business processesSuzanne Mieczkowska, Matthew Hinton, David Barnes
Hospital Pharmacy|October 20, 2025
Risk Factors Associated with Thrombus Development Following Pharmacologic Anticoagulation Reversal with Coagulation Factor Xa [Recombinant], Inactivated-zhzoDavid Zingale, Raymond Lamore, Derek Peiffer, et al.
Open Forum Infectious Diseases|August 13, 2025
Clinical Microbiology in Xylazine-Associated Wound InfectionsDeanna M Berg, Amanda Binkley, Sean D Foster, et al.
Pageof 1